www.encognitive.com It’s been said that statistics is the only field where two people can draw different conclusions on the same set of data. For example, chemotherapy’s estimated efficacy rate is 3% to 80%. This wide gap depends on whether you’re using the 5 year survival rate defined by the American Cancer Society or the total life survival rate. 1. So, what is chemotherapy? It is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. It was invented around WWII from the poisonous nerve gas called Mustard Gas. 2. It is very difficult to discuss any success rates for treating lung cancer with chemo, radiation, surgery or a combination of those, because it depends on many variables — type and stage of cancer, its location and size, the age and health of the patient, and so on. Very generally, for non-small cell lung cancer 5 year survival rate varies from up to 80% at stage I to less than 1% at stage IV. For small-cell lung cancer, same rate for limited stage is bout 10% and none for extensive stage. 3. So, basically, the success in curing lung cancer is dismally low. Even with early detection and screening programs for lung cancer, many studies show no significant survival benefit. And since the majority of lung cancer is diagnosed at a relatively late stage, only about 10% of all lung cancer patients are ultimately cured. 4. There is a rather large variety of alternative lung cancer …

Lung cancer requires different kinds of treatment from several different specialties, says lung cancer expert Mark G. Kris, MD, fromMemorial Sloan-Kettering Cancer Center in this video from the National Comprehensive Cancer Network (NCCN). The NCCN, a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care for patients with cancer. For more free expert information on lung cancer and other cancers, including the NCCN Guidelines for Patients, visit www.NCCN.com.

Thoracic Malignancies:

Thoracic Malignancies is the first title in Radiation Medicine Rounds. These tumors take more lives than any others and they are among the most preventable of tumors. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management.

Thoracic Malignancies addresses the multi-disciplinary nature of the care of these tumors. There is representation from radiation oncology, medical oncology, and surgery ensuring a well-rounded summarization of current practice. Included are chapters on lung cancer, esophageal cancer, and thymomas providing coverage of the vast majority of thoracic tumors. The multi-disciplinary nature of the articles provides readers with an up-to-date summary and a well-rounded review regarding these tumors and their care. Expert authors provide reviews and assessments of the most recent data and its implications for current clinical practice, along with insights into emerging new trends of importance for the near future.

About the Series
Radiation Medicine Rounds is an invited review publication providing a thorough analysis of new scientific, technologic, and clinical advances in all areas of radiation medicine. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis.

Published three times a year Radiation Medicine Rounds provides authoritative, thorough assessments of a wide range of “hot topics” and emerging new data for the entire specialty of radiation medicine.

Features of Radiation Medicine Rounds include:

• Editorial board of nationally recognized experts across the spectrum of radiation medicine
• In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine
• Issues edited by an authority in specific subject area
• Focuses on major topics in Radiation Medicine with in-depth articles covering advances in radiation science radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcomes studies
• Emphasizes multidisciplinary approaches to research and practice

List Price: $ 85.00

Click the link below to read product reviews and buy on Amazon.com if you like it :-

Thoracic Malignancies (Radiation Medicine Rounds Volume 1 Issue 1)

Lung cancer and esophageal cancer are very aggressive diseases. Early detection is essential. Acting quickly and decisively can make the difference between a cure and a life-limiting situation. The need to have in place a system to encompass the prompt diagnosis and care of a cancer that often involves complex treatment plans and coordination of services triggered the creation of the multidisciplinary Thoracic Oncology Program at Shands Jacksonville. More information at jax.shands.org

An informative, compassionate guide for cancer patients and their loved ones

Each year, more than 1 million people get treated for cancer, and most of these will undergo chemotherapy, radiation therapy, or both. This reassuring, optimistic guide helps people get a handle on treatment options and explains in plain English how chemotherapy and radiation therapy really work. It offers detailed advice on how to alleviate and cope with side effects-which range from hair loss to nausea to anemia-and describes how good nutrition, meditation, support groups, and other techniques and resources can help in the recovery process.

• ISBN13: 9780764578328
• Condition: New
• Notes: BRAND NEW FROM PUBLISHER! 100% Satisfaction Guarantee. Tracking provided on most orders. Buy with Confidence! Millions of books sold!

List Price: $ 21.99

Click the link below to read product reviews and buy on Amazon.com if you like it :-

Chemotherapy and Radiation For Dummies